Streetbeat News

Products Services

QUIK

QuickLogic is set to showcase its eFPGA technology and Australis Hard IP Generator at DAC 2024, highlighting its advancements in programmable logic solutions.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 9:11 pm

CLW

Clearwater Paper plans to invest $23 million in a new facial tissue converting line at its Shelby, North Carolina facility, which manufactures private branded bathroom tissue, paper towels, napkins, and facial tissue. The facility employs over 600 people.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 9:09 pm

OII

Oceaneering International (OII) has secured a significant contract worth approximately $50 million from a domestic independent energy company. The contract involves supplying an electro-hydraulic, steel tube dynamic umbilical for a project in the Gulf of Mexico. Manufacturing will begin in 2025 at the Panama City, Florida facility, with final delivery expected in Q2 2026.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 9:06 pm

SRPT

Sarepta Therapeutics has received expanded FDA approval for its drug ELEVIDYS to treat Duchenne Muscular Dystrophy (DMD) in patients aged 4 and above. The FDA granted traditional approval for ambulatory patients and accelerated approval for non-ambulatory patients, with continued approval contingent on a confirmatory trial. ELEVIDYS is contraindicated for patients with deletions in exon 8 and/or exon 9 in the DMD gene.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 9:04 pm

T

The California Public Utilities Commission has rejected AT&T's request to withdraw as a telecommunications carrier for 580,000 households in the state.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 8:50 pm

RKLB

Rocket Lab successfully launched its 50th Electron mission, deploying satellites for the French IoT company Kinéis.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 8:49 pm

CLLS

Cellectis has published a scientific article highlighting three key factors for efficient TALE base editing. This development could have significant implications for the company's research and development efforts.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 8:31 pm

JNJ

Johnson & Johnson has submitted an application to the FDA for the approval of TREMFYA for the treatment of moderately to severely active Crohn's disease. The submission is backed by 48-week results from the Phase 3 GALAXI and GRAVITI programs, showing strong endoscopic outcomes with both subcutaneous and intravenous induction therapies.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 8:30 pm

AMZN

GOOG

GOOGL

MSFT

ROKU

SONY

VZIO

WMT

Roku, Inc. (NASDAQ:ROKU) is experiencing a bull-bear debate as analysts weigh its growth potential against competitive threats. Needham analyst Laura Martin maintains a Buy rating with a $100 price target, citing revenue opportunities from programmatic CTV ad sales, subscription revenue shares, home page monetization, and CTV data revenue. However, competition from larger companies like Google, Amazon, Microsoft, and Sony, as well as rising content costs and Walmart's acquisition of Vizio, pose significant risks.

Portfolio Pulse from Surbhi Jain

June 20, 2024 | 8:22 pm

NBR

Nabors Industries CFO William Restrepo participated in the J.P. Morgan Energy, Power & Renewables Conference, confirming strong activity and financial results in both international and U.S. drilling segments. He highlighted a positive outlook for drilling solutions and maintained the 2024 capital expenditures estimate at $590 million.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2024 | 8:16 pm